Responses to 'Decision to reject screening for familial hypercholesterolaemia is flawed' by Wald and Martin

Arch Dis Child. 2022 Jan;107(1):102. doi: 10.1136/archdischild-2021-322642. Epub 2021 Jul 21.

Authors

John Marshall¹, Graham Shortland Obe², Sharon Hillier², Roger Brownsword², Bob Steele²

Affiliations

¹ UK National Screening Committee, London, UK john.marshall@phe.gov.uk.
² UK National Screening Committee, London, UK.

PMID: 34289993
DOI: 10.1136/archdischild-2021-322642

No abstract available

Keywords: child health; paediatrics.

Publication types

Letter
Comment

MeSH terms

Humans
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / genetics
Mass Screening
Research